Medicine
Draximage Maa 2.5 mg powder for injection
Draximage Maa 2.5 mg powder for injection is a prescription medicine containing Albumin aggregated for intravenous use, marketed by Jubilant DraxImage, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
After radiolabeling with Sodium Pertechnetate Tc 99m Injection, store…
Key facts
- Active ingredient (INN)
- Albumin aggregated
- Brand
- Draximage Maa
- Strength
- 2.5 mg
- Dosage form
- Powder for injection
- Route
- Intravenous
- Packs
- 30 injection
- Marketing authorisation holder
- Jubilant DraxImage
- Manufacturer
- Jubilant DraxImageIndia
- Origin register
- US FDA, United States
- Storage
- After radiolabeling with Sodium Pertechnetate Tc 99m Injection, store Technetium Tc 99m Albumin Aggregated Injection in a lead vial shield with cap in place, refrigerated at 2 ºC to 8 ºC (36 ºF to 46 ºF) when not in use. Before radiolabeling, store the supplied reaction vials at 2 ºC to 25ºC (36 ºF to 77 ºF).
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3002.12Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 30 December 1987
- Identifiers
- DailyMed set ID bbefaa05-1dc0-3ae7-7264-ce1eddf0da2bNDC 65174-270Application BLA017881
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 injection, powder, for solution in 1 kit | 65174-270-30 | Jubilant DraxImageIndia | 30 December 1987 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Albumin aggregated
Clinical summary
Albumin aggregated is a prescription medicine indicated for lung scintigraphy as an adjunct in the evaluation of pulmonary perfusion in adults and pediatric patients. MedsAcross supplies Albumin aggregated for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Albumin aggregatedFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Pulmotech MAA prescribing information (Curium) · U.S. National Library of Medicine, DailyMed
Need Draximage Maa 2.5 mg powder for injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.